The Bridge Comes With a Clock
Medicare’s GLP-1 Bridge is real access on a fixed clock, and the builder move is to treat it as a window, not a win.
NO FLUFF FRIDAY
Opinions are my own and do not represent my employer.
● THE SIGNAL
Real access landed July 1. Eligible Medicare Part D patients can now get the leading GLP-1s for weight management at a $50 copay.
For a population that had no covered path and faced direct-pharmacy prices starting near $150 a month, that is a real change. Patients I could not reach last week are reachable now.
● THE NOISE
The celebration is flattening two things. The first is eligibility. The Bridge sets its bar above the FDA label: uncomplicated obesity qualifies only at a BMI of 35, and the lower thresholds require specific cardiometabolic disease. Not everyone who wants these drugs will qualify.
The second is permanence. The posts read as if coverage arrived to stay. It did not.
● THE REFRAME
The Bridge is a demonstration, not a benefit. It runs through December 31, 2027, and exists in part to collect utilization data ahead of a decision about a permanent Part D pathway.
That is not a reason for cynicism. It is a reason for urgency. Access that arrives on a clock behaves differently from access that arrives to stay.
Legacy reads a CMS demonstration as a headline to celebrate or a criterion to complain about. Builder reads it as a window and asks how many patients can move through it before it closes.
● THE BUILD
Treat the next eighteen months as the window. Identify the patients who qualify under the criteria now. Document the attestation and the history at initiation cleanly, because clean starts survive audits and renewals.
Do not wait for the bar to drop. Move the patients you can reach today, and let the utilization you generate become the evidence that argues for a permanent pathway.
● THIS WEEK’S NFF SCORE
🟢 Signal — A $50 copay put a whole class of Medicare patients back within reach of the right drug.
🔴 Theater — Framing a time-boxed demonstration as a permanent win that covers everyone who wants it.
🟡 Noise — Complaint threads about the raised criteria that move no patient and build no workflow.
This lands from the quality seat. The pathway that survives audit and renewal is the one where the documentation falls out of the workflow itself, so attestation becomes a byproduct of good care rather than a second job competing with it. The window rewards whoever builds that habit early, because once the criteria harden you are already running the case you would want examined.